QSAR Classification of Beta-Secretase 1 Inhibitor Activity in Alzheimer's Disease Using Ensemble Machine Learning Algorithms
暂无分享,去创建一个
[1] K. Camphausen,et al. Hierarchical Voting-Based Feature Selection and Ensemble Learning Model Scheme for Glioma Grading with Clinical and Molecular Characteristics , 2022, International journal of molecular sciences.
[2] D. Fairlie,et al. QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites. , 2022, ACS infectious diseases.
[3] Yongzhen Peng,et al. Quantitative Structure-Activity Relationship (QSAR) Studies on the Toxic Effects of Nitroaromatic Compounds (NACs): A Systematic Review , 2021, International journal of molecular sciences.
[4] Irvanizam Irvanizam,et al. Application of Genetic Algorithm-Multiple Linear Regression and Artificial Neural Network Determinations for Prediction of Kovats Retention Index , 2021 .
[5] A. Yan,et al. SAR and QSAR research on tyrosinase inhibitors using machine learning methods , 2021, SAR and QSAR in environmental research.
[6] Yu Kang,et al. Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets , 2020, Briefings Bioinform..
[7] Piyali Mukherjee,et al. Flavonoids as BACE1 inhibitors: QSAR modelling, screening and in vitro evaluation. , 2020, International journal of biological macromolecules.
[8] I. Kurniawan,et al. Implementation of ensemble methods on QSAR Study of NS3 inhibitor activity as anti-dengue agent , 2020, SAR and QSAR in environmental research.
[9] Artem Cherkasov,et al. QSAR without borders. , 2020, Chemical Society reviews.
[10] Gideon Adamu Shallangwa,et al. In silico QSAR and molecular docking simulation of some novel aryl sulfonamide derivatives as inhibitors of H5N1 influenza A virus subtype , 2020, Beni-Suef University Journal of Basic and Applied Sciences.
[11] T. Al‐Tel,et al. BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease , 2020, Medicinal research reviews.
[12] D. Seripa,et al. Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease , 2019, GeroScience.
[13] Sungroh Yoon,et al. Comprehensive ensemble in QSAR prediction for drug discovery , 2019, BMC Bioinformatics.
[14] Maria Vanina Martinez,et al. QSAR Classification Models for Predicting the Activity of Inhibitors of Beta-Secretase (BACE1) Associated with Alzheimer’s Disease , 2019, Scientific Reports.
[15] R. Dhanalakshmi,et al. Stability of feature selection algorithm: A review , 2019, J. King Saud Univ. Comput. Inf. Sci..
[16] Tatsuya Takagi,et al. Mordred: a molecular descriptor calculator , 2018, Journal of Cheminformatics.
[17] Virapong Prachayasittikul,et al. Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking , 2016, PeerJ.
[18] Ashok Sharma,et al. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis , 2016, Journal of biomolecular structure & dynamics.
[19] R. Vassar. BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.
[20] Alois Knoll,et al. Gradient boosting machines, a tutorial , 2013, Front. Neurorobot..
[21] Ying Cao,et al. Advance and Prospects of AdaBoost Algorithm , 2013, Acta Automatica Sinica.
[22] Bieke Dejaegher,et al. Feature selection methods in QSAR studies. , 2012, Journal of AOAC International.
[23] Pierre Geurts,et al. Extremely randomized trees , 2006, Machine Learning.
[24] Roberto Todeschini,et al. Impact of Molecular Descriptors on Computational Models. , 2018, Methods in molecular biology.